Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade C 7.87 -1.50% -0.12
HROW closed down 1.5 percent on Thursday, July 18, 2019, on 51 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Aug 6

*** please verify all earnings dates ***
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical HROW trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Inside Day Range Contraction -1.50%
20 DMA Support Bullish 0.51%
Wide Bands Range Expansion 0.51%
Wide Bands Range Expansion -1.63%

Older signals for HROW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 10 Do Insiders Own Shares In Harrow Health, Inc. (NASDAQ:HROW)?
Jul 1 Aclaris Therapeutics and Precipio among healthcare gainers; Evofem Biosciences leads the losers
Jun 25 Amid Bay Area exodus, Nashville is rockin’
Jun 25 Harrow Health Adds Two Senior Executives to its Nashville Team
Jun 19 The city's newest public company wants to build a new industry in Nashville
Jun 18 Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee
Jun 18 Publicly traded San Diego firm moving HQ to Nashville
May 31 Harrow Health, Inc. Is Quickly Taking Over The Ophthalmology Pharmaceutical Market
May 30 Novel Drug Solutions, LLC and Eye Care Northwest, PA Terminates Agreement with Harrow Health, Inc.
May 29 Harrow Health Announces Renegotiated Debt Facility with SWK Holdings
See more HROW news...
Indicators
Indicator Value
52 Week High 8.99
52 Week Low 2.22
Average Volume 335,076
200-Day Moving Average 5.4146
50-Day Moving Average 6.6248
20-Day Moving Average 7.8015
10-Day Moving Average 7.886
Average True Range 0.4471
ADX 47.04
+DI 25.103
-DI 10.0872
Chandelier Exit (Long, 3 ATRs ) 7.6487
Chandelier Exit (Short, 3 ATRs ) 7.1813
Upper Bollinger Band 8.6393
Lower Bollinger Band 6.9637
Percent B (%b) 0.54
BandWidth 21.477921
MACD Line 0.3985
MACD Signal Line 0.4711
MACD Histogram -0.0726
Fundamentals Value
Market Cap 157.9 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -9.72
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.05
Resistance 3 (R3) 8.06 8.01 8.02
Resistance 2 (R2) 8.01 7.96 8.01 8.01
Resistance 1 (R1) 7.94 7.94 7.92 7.93 8.00
Pivot Point 7.89 7.89 7.88 7.89 7.89
Support 1 (S1) 7.82 7.84 7.80 7.81 7.74
Support 2 (S2) 7.77 7.82 7.77 7.73
Support 3 (S3) 7.70 7.77 7.72
Support 4 (S4) 7.69